Meeting
2024 ASCO Genitourinary Cancers Symposium
Detection and delineation of intraprostatic lesions (IPLs) using multiparametric magnetic resonance imaging (mpMRI) and prostate specific membrane antigen positron emission tomography (PSMA PET) for patients with prostate cancer: A systematic review and meta-analysis.
Authors
Aneesh Dhar
London Regional Cancer Program, Western Univeristy, London, ON, Canada
Aneesh Dhar , Lucas Mendez , Jose de Jesus Cendejas-Gomez , Gabriel Boldt , Eric McArthur , Constantinos Zamboglou , Glenn Bauman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 287)
DOI
10.1200/JCO.2024.42.4_suppl.287
Abstract #
287
Poster Bd #
L22
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Daro-PET: A phase 2 trial of darolutamide as a prostate-specific membrane antigen (PSMA) expression enhancer in patients with localized prostate cancer.
First Author: Jose Mauricio Mota
Poster
2023 ASCO Annual Meeting
PSMA PET findings in an “EMBARK-like” cohort of patients with high-risk non-metastatic hormone-sensitive prostate cancer: A single center post-hoc retrospective analysis.
First Author: Wesley Robert Armstrong
Poster
2020 Genitourinary Cancers Symposium
Adjuvant radiotherapy following radical prostatectomy for prostate cancer: A systematic review and meta-analysis.
First Author: Tobias Engel Ayer Botrel
Poster
2020 Genitourinary Cancers Symposium
Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer.
First Author: Romain Schollhammer Sr.